David Ennist
David Ennist
Origent Data Sciences, Inc.
Bestätigte E-Mail-Adresse bei origent.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide
DE Brenneman, GL Westbrook, SP Fitzgerald, DL Ennist, KL Elkins, ...
Nature 335 (6191), 639-642, 1988
7301988
An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.
PH Driggers, DL Ennist, SL Gleason, WH Mak, MS Marks, BZ Levi, ...
Proceedings of the National Academy of Sciences 87 (10), 3743-3747, 1990
4211990
Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus
JR Flanagan, KG Becker, DL Ennist, SL Gleason, PH Driggers, BZ Levi, ...
Molecular and cellular biology 12 (1), 38-44, 1992
3081992
The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds
Y Kanno, CA Kozak, C Schindler, PH Driggers, DL Ennist, SL Gleason, ...
Molecular and cellular biology 13 (7), 3951-3963, 1993
2091993
Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
K Otake, DL Ennist, K Harrod, BC Trapnell
Human gene therapy 9 (15), 2207-2222, 1998
1831998
CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor–armed oncolytic adenovirus for the treatment of bladder cancer
N Ramesh, Y Ge, DL Ennist, M Zhu, M Mina, S Ganesh, PS Reddy, DC Yu
Clinical cancer research 12 (1), 305-313, 2006
1742006
Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir
NC Munshi, R Govindarajan, R Drake, LM Ding, R Iyer, R Saylors, ...
Blood, The Journal of the American Society of Hematology 89 (4), 1334-1340, 1997
1101997
In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF
JA Bristol, M Zhu, H Ji, M Mina, Y Xie, L Clarke, S Forry-Schaudies, ...
Molecular Therapy 7 (6), 755-764, 2003
882003
Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells
Z Long, LP Li, T Grooms, C Lockey, K Nader, I Mychkovsky, S Mueller, ...
Human gene therapy 9 (8), 1165-1172, 1998
631998
Modulation of immune responses by surface polysaccharides of Candida albicans
J Domer, K Elkins, D Ennist, P Baker
Reviews of infectious diseases, S419-S422, 1988
511988
Rapid method for identification of macrophages in suspension by acid alpha-naphthyl acetate esterase activity.
DL Ennist, KH Jones
Journal of Histochemistry & Cytochemistry 31 (7), 960-963, 1983
481983
Predicting disease progression in amyotrophic lateral sclerosis
AA Taylor, C Fournier, M Polak, L Wang, N Zach, M Keymer, JD Glass, ...
Annals of Clinical and Translational Neurology 3 (11), 866-875, 2016
442016
Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM …
DL Ennist, KH Jones, RL St Pierre, RL Whisler
The Journal of Immunology 136 (1), 99-105, 1986
381986
Being PRO-ACTive: what can a clinical trial database reveal about ALS?
N Zach, DL Ennist, AA Taylor, H Alon, A Sherman, R Kueffner, J Walker, ...
Neurotherapeutics 12 (2), 417-423, 2015
362015
Novel oncolytic adenoviral vectors
C Cheng, L Clarke, S Connelly, D Ennist, S Forry-Schaudies, M Gorziglia, ...
US Patent App. 10/081,969, 2003
342003
In Vivo Delivery of Interleukin-4 by a Recombinant Vaccinia Virus Prevents Tumor Development in Mice
KL Elkins, DL Ennist, RK Winegar, JP Weir
Human gene therapy 5 (7), 809-820, 1994
341994
Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses
M Zhu, JA Bristol, Y Xie, M Mina, H Ji, S Forry-Schaudies, DL Ennist
Journal of virology 79 (9), 5455-5465, 2005
232005
Gene therapy for lung disease
DL Ennist
Trends in pharmacological sciences 20 (6), 260-266, 1999
231999
Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL
KD Burroughs, DB Kayda, K Sakhuja, Y Hudson, J Jakubczak, JA Bristol, ...
Cancer gene therapy 11 (2), 92-102, 2004
172004
Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein
JE Domer, KL Elkins, DL Ennist, PW Stashak, RE Garner, PJ Baker
Infection and immunity 55 (11), 2619-2624, 1987
171987
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20